1. Zadegan SN, Sadri G, Malek AH, Baghaei
M, Mohammadi FN et al. (2003). Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol. 58: 309-20.
2. Stanciu I, Peralta MI, Emanuele MA, Emanuele
NV (2002). Clinical trial evidence for cardiovascular risk reduction in type 2 diabetes. J Cardiovas Nurs. 16: 24–43.
3. Gill GV, Woodward A, Pradhan S, et al. (2003).
Intensified treatment of type 2 diabetes – positive effects on blood pressure, but not glycaemic control. QJM. 96: 833–6.
4. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM (2001). Excess mortality in a population with diabetes and the impact of material deprivation: Longitudinal, population based study. BMJ. 322: 1389–93.
5. Wang L, Wei T (2006). Blood pressure control in patients with hypertension: A community-based study. Clin Exp Hypertens. 28: 41–6.
6. Alireza E, Alipasha M, Mehrshad A (2009). Third national surveillance of risk factors of non- communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia, biomedical central, BMC public health. 9: 167.
7. Ericka MC, Carolina SU, Luis RB (2008). Factors associated with hypertension prevalence, unawareness and treatment among Costa Rican elderly. BMC Public Health. 8: 275.
8. Abdolmehdi B, Nizal S, Katayoun R, Mojgan G, Ali AT, et al (2010). How effective are strategies for non-communicable disease prevention and control in a high risk population in a developing country? Isfahan Healthy Heart Programme. Arch Med Sci. 6: 24-31.
9. Ahmad RH, Nicole B, Anton K, Sam H, Regina G, Dag R, et al (2012). Socioeconomic inequalities in risk factors for non-communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Public Health. 12: 912.
10. Samim AA, Sirwan MA (2010). Compliance of Hypertensive Patients To Management In Duhok Governorate Using Morisky-Green Test. Duhok Medical Journal. 4: 33-37.
11. Fereidoun A, Arash G, Amir AM, Farzad H, Parvin M, et al. (2009). Prevention of non- communicable disease in a population innutrition transition: Tehran Lipid and Glucose Study phase. BioMed Central. 25: 10-5.
12. Abbas AM (2012). Prevalence and Control of Hypertension in Iraqi Diabetic Patients: A Prospective Cohort Study. Open Cardiovasc Med J. 6: 68–7.
13. Abbas AM, Narjis AA (2013). Atherosclerotic cardiovascular disease among patients with type
2 diabetes in Basrah, World J Diabetes. 4: 82–
14. Musinguzi G, Nuwaha F (2013). Prevalence, Awareness and Control of Hypertension in Uganda. Plose one. 8: 4.
15. Upali WJ, Mark FH, Jane T (2013). Bettina C and Deborah AB. Gender differences in healthrelated quality of life of Australian chronically-ill adults: patient and physician characteristics do matter, Health and Quality of Life Outcomes. 11: 102.
16. Kareem JS, Saaed SQ, Hasan BA, Abdulla MK (2015). Assessment of Health Related to Quality of Life in Hypertensive and Diabetic Mellitus patients in Kurdistan/Iraq. Kufa journal for nursing sciences. 3: 1-11.
17. Bramley TJ, Gerbino PP, Nightengale BS, Frech TF (2006). Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 12: 239-45.
18. Emma LC, Margaret MC, Claire MB, Anthony PF, Ivan JP (2013). Unhealthy Days and Quality of Life in Irish Patients with Diabetes, PLoS One. 8: 1-12.
19. Carma A, Jing F, Luis E, Stephen P, Hector GB., et al (2012). Actions to Control High Blood Pressure Among Hypertensive Adults in Texas Counties Along the Mexico Border. Public Health Rep. 127: 173-85.